Sanofi Genzyme is expanding its Multiple Myeloma Journey Partners Program, which uses storytelling as a tool to help multiple myeloma patients and caregivers.
"Sanofi Genzyme created the Multiple Myeloma Journey Partners Program to let multiple myeloma patients know they are not alone and to provide educational resources and services that help patients and families navigate their journey to achieve the best possible outcomes," Sanofi Genzyme Vice President and General Manager of US Oncology Bhavesh Ashar said in a press release."As a company, we value the importance of taking a holistic approach to patient care and transforming the patient experience. There's a real power in telling and listening to personal narratives. It helps increase the knowledge base of patients and caregivers and makes them feel supported."
The peer-to-peer education program is a free one-hour educational seminar. Journey Partners share their experiences when they underwent autologous stem cell transplants (ASCT) with other patients and caregivers. The session also provides resources and encourages patients to consider ASCT evaluations, according to the release.
"It was conversations with my support group, family and healthcare providers that influenced my decision to have a stem cell transplant in 2008 when I was first diagnosed with multiple myeloma at the age of 65," Multiple Myeloma Journey Partner John Killip said. " Mentoring other myeloma patients is one of the highlights of my life and I became a Journey Partner to share my story and help others with multiple myeloma make sense of the diagnosis and overcome the fear of the unknown."
